Literature DB >> 25491784

A Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the Thyroid.

Ga Young Kim1, Chul Yun Park1, Chang Ho Cho2, June Sik Park3, Eui Dal Jung1, Eon Ju Jeon4.   

Abstract

Neuroendocrine lesions of the thyroid are rare. The most common types are medullary thyroid carcinomas (MTCs) and C-cell hyperplasia. MTCs originate from thyroid parafollicular cells that secrete calcitonin which serves as a serum marker of MTCs. Here, the rare case of a calcitonin-negative neuroendocrine tumor (NET) derived from follicular lesions of the thyroid is described. A 34-year-old man presented at our hospital for the surgical management of an incidental thyroid nodule that was observed on an ultrasound sonography (USG) of the neck. Initially, USG-guided aspiration cytology was performed, and a MTC was suspected. The expressions of thyroglobulin and thyroid transcription factor-1, which are thyroid follicular cell markers, and synaptophysin and chromogranin A, which are neuroendocrine markers, was confirmed following surgical pathology. However, the staining of calcitonin, a marker of MTCs, was not observed. A nonmedullary NET of the thyroid is uncommon, and the distinction between calcitonin-negative NETs and MTCs of the thyroid may be important due to differences in their clinical courses and management.

Entities:  

Keywords:  Calcitonin; Carcinoma, medullary; Neuroendocrine tumors

Year:  2014        PMID: 25491784      PMCID: PMC4508268          DOI: 10.3803/EnM.2015.30.2.221

Source DB:  PubMed          Journal:  Endocrinol Metab (Seoul)        ISSN: 2093-596X


  13 in total

1.  Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.

Authors:  Victoriya S Chernyavsky; Saima Farghani; Tomer Davidov; Ly Ma; Nicola Barnard; Louis F Amorosa; Stanley Z Trooskin
Journal:  Thyroid       Date:  2011-02       Impact factor: 6.568

Review 2.  The neuroendocrine concept today.

Authors:  K Langley
Journal:  Ann N Y Acad Sci       Date:  1994-09-15       Impact factor: 5.691

3.  Early diagnosis and treatment of medullary thyroid carcinoma.

Authors:  S A Wells; W G Dilley; J A Farndon; G S Leight; S B Baylin
Journal:  Arch Intern Med       Date:  1985-07

Review 4.  Neuroendocrine tumors of the thyroid gland.

Authors:  Z W Baloch; V A LiVolsi
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

5.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].

Authors:  S A Hundahl; I D Fleming; A M Fremgen; H R Menck
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

Review 6.  Unusual tumors of the thyroid gland.

Authors:  Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocrinol Metab Clin North Am       Date:  2008-06       Impact factor: 4.741

Review 7.  Medullary thyroid carcinoma: recent advances and management update.

Authors:  D J Marsh; D L Learoyd; B G Robinson
Journal:  Thyroid       Date:  1995-10       Impact factor: 6.568

8.  Radiation-associated small cell neuroendocrine carcinoma of the thyroid: a case report with molecular analyses.

Authors:  Zhanna Mussazhanova; Shiro Miura; Boban Stanojevic; Tatiana Rougounovitch; Vladimir Saenko; Toshio Shiraishi; Tomomi Kurashige; Kazuko Shichijo; Kenichi Kaneko; Haruo Takahashi; Masahiro Ito; Masahiro Nakashima
Journal:  Thyroid       Date:  2014-01-15       Impact factor: 6.568

Review 9.  Medullary thyroid cancer: management guidelines of the American Thyroid Association.

Authors:  Richard T Kloos; Charis Eng; Douglas B Evans; Gary L Francis; Robert F Gagel; Hossein Gharib; Jeffrey F Moley; Furio Pacini; Matthew D Ringel; Martin Schlumberger; Samuel A Wells
Journal:  Thyroid       Date:  2009-06       Impact factor: 6.568

Review 10.  Medullary thyroid carcinoma.

Authors:  Marcio L Griebeler; Hossein Gharib; Geoffrey B Thompson
Journal:  Endocr Pract       Date:  2013 Jul-Aug       Impact factor: 3.443

View more
  4 in total

1.  Calcitonin-negative neuroendocrine tumor of the thyroid with metastasis to liver-rare presentation of an unusual tumor: A case report and review of literature.

Authors:  Huai-Jie Cai; Han Wang; Nan Cao; Bin Huang; Fan-Lei Kong; Li-Ren Lu; Ya-Yuan Huang; Wei Wang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

2.  Calcitonin-negative primary neuroendocrine tumor of the thyroid (nonmedullary) in a dog.

Authors:  E A Soler Arias; V A Castillo; M E Caneda Aristarain
Journal:  Open Vet J       Date:  2016-11-17

Review 3.  Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.

Authors:  Claudio Gambardella; Chiara Offi; Guglielmo Clarizia; Roberto Maria Romano; Immacolata Cozzolino; Marco Montella; Rosa Maria Di Crescenzo; Massimo Mascolo; Angelo Cangiano; Sergio Di Martino; Giancarlo Candela; Giovanni Docimo
Journal:  BMC Endocr Disord       Date:  2019-10-16       Impact factor: 2.763

Review 4.  An encapsulated oncoytic neoplasm of follicular origin of thyroid, expressing neuroendocrine markers. A case report and literature review.

Authors:  Marcello Filotico; Francesca Plutino
Journal:  Pathologica       Date:  2021-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.